Clinical Trial Update: Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing the Combo Stent from OrbusNeich to an everolimus-eluting stent in acute coronary syndrome, assessed with optical coherence to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease
• Coronary Syndrome
• Myocardial Infarction

Drugs mentioned

• COMBO Stent
• Everolimus-eluting stent (everolimus-eluting stent)

Snippet

Sponsor: OrbusNeich | Conditions: Coronary Artery Disease, Atherosclerosis | Phase 2 | Status: COMPLETED